A polymorphism in the AT-hook motif of the transcriptional regulator AKNA is a risk factor for cervical cancer

Biomarkers

Volumn 15, Issue 5, 2010, Pages 470-474

  Perales, Guillermo ^a   Burguete García, Ana I ^a   Dimas, Jisela ^a   Bahena Román, Margarita ^a   Bermúdez Morales, Víctor H ^a   Moreno, José ^a   Madrid Marina, Vicente ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

AKNA; AT hook motif; Cervical cancer; HPV; RFLP; Risk factor; SNPs

Indexed keywords

AKNA PROTEIN; AMINO ACID; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; AT HOOK MOTIF; CANCER PATIENT; CANCER RISK; CODON; DNA BINDING; GENE FREQUENCY; GENOTYPE; HEREDITY; HOMOZYGOSITY; HUMAN; NUCLEOTIDE SEQUENCE; PROTEIN POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; ALLELES; AT-HOOK MOTIFS; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; NUCLEAR PROTEINS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TRANSCRIPTION FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 77954854709     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2010.485332     Document Type: Article

References (22)

1. Aravind L, Landsman D. (1998). AT-hook motifs identified in a wide variety of DNA-binding protein. Nucleic Acids Res 26:4413-4421
2. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton CL, Bauer HM, Wheeler CM. (1994). Identification and assessment of known and novel human papilloma viruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 70:1077-1085
3. Cairns B, Schlinchter A, Erdjument B, Tempst P, Kornberg R, Winston F. (1999). Two functionally distinct forms of the RSC nucleosome-remodeling complex, containing essential AT-hook, BAH, and bromodomains. Mol Cell 4:715-723
4. Calhoun E, McGovern R, Janney C, Cerhan J, Iturria S, Smith D, Gostout B, Persing D. (2002). Host genetic polymorphism analysis in cervical cancer. Clin Chem 48:1218-1224
5. Dokianakis D, Spandidos D. (2000). p53 Codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer. Mol Cell Biol Res Commun 3:111-114
6. Engelmark MT, Ivansson EL, Magnusson JJ, Gustavsson IM, Beskow AH, Magnusson PK, Gyllensten UB. (2006). Identification of susceptibility loci for cervical carcinoma by genome scan of affected sib-pairs. Hum Mol Genet 15:3351-3360
7. Ford B, Ruttan C, Kyle V, Brackley M, Glickman B. (2000). Identification of single nucleotide polymorphism in human DNA repair genes. Carcinogenesis 21:1977-1981
8. Huth J, Bewley C, Nissen M, Evans J, Reeves R, Gronenborn A, Clore G. (1997). The solution structure of an HMG-I(Y)-DNA complex defines a new architectural minor groove binding motif. Nat Struct Biol 8:657-665
9. International SNP Map Working Group. (2001). A map of human genome sequence variation containing 1.42 million of single nucleotide polymorphism. Nature 409:928-933
10. Kirkpatrick A, Bidwell J, van den Brule A, Meiler C, Pawad J, Glew S. (2004). TNF-polymorphism frequencies in HPV-associated cervical dysplasia. Gynecol Oncol 92:675-679
11. Lai H, Sytwu H, Sun C, Yu C, Liu H, Chang C, Chu T. (2003). Single Nucleotide Polymorphism at Fas promoter is associates with Cervical Carcinogenesis. Int J Cancer 103:221-225
12. Makni H, Franco E, Kaiano J, Villa L, Labrecque S, Dudley R, Storey A, Matlashewski G. (2000). p53 polymorphism in codon 72 and risk of human papilloma virus-induced cervical cancer: effect of inter-laboratory variation. Int J Cancer; 87:528-533
13. Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, and others. (2004). Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet 36:40-45
14. Sgarra R, Lee J, Tessari MA, Altamura S, Spolaore B, Giancotti V, Bedford MT, Manfioletti G. (2006). The AT-hook of the chromatin architectural transcription factor high mobility group A1 a is arginine-methylated by protein arginine methyltransferase 6 J Biol Chem 281:3764-3772
15. Siddiqa A, Sims M, Guzman-Rojas L, Rangel R, Guret C, Madrid M, Sun Y, Martinez-Valdez H. (2001). Regulation of CD40 and CD40 ligand by the AT-hook transcription factor AKNA. Nature 410:383-387
16. Sims-Mourtada JC, Bruce S, McKeller MR, Rangel R, Guzmán-Rojas L, Cain K, Lopez C, Zimonjic DB, Popescu NC, Gordon J, Wilkinson MF, Martinez-Valdez H. (2005). The human Akna gene expresses multiple transcripts and protein isoforms as a result of alternative promoter usage, splicing, and poly-adenylation. DNA Cell Biology 24:5325-5338
17. Tenti R, Vesentini N, Rondo S, Zappatore R, Migliora P, Carnevali L, Ranzani G. (2000). p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from Northern Italy. Cancer Epidemiol Biomarkers Prev 9:435-438
18. Walboomers J, Jacobs M, Manos M, Bosch F, Kumer J, Shah K, Snijders P, Peto J, Meijer C, Muñoz N. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
19. Walters MS, Hall KT, Whitehouse A. (2004). The herpesvirus saimiri open reading frame (ORF) 50 (Rta) protein contains an AT-hook required for binding to the ORF 50 response element in delayedearly promoters. J Virol 78:9;4936-4942
20. Wilson A, Symons J, McDowell T, McDevitt H, Duff G. (1997). Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195-3199
21. Yoshikawa H, Kawana T, Kitagawa K, Mizuno M, Yoshikura H, Iwamoto A. (1991) Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res 82:524-531
22. Zur Hausen H. (1996). Papillomavirus infections a major cause of human cancers. Biochim Biophys Acta 1288:F55-78.